Phase II study of axitinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma

被引：5
|
作者：
Ho, Alan Loh
Sherman, Eric Jeffrey
Fury, Matthew G.
Baxi, Shrujal S.
Haque, Sofia
Sima, Camelia S.
Antonescu, Cristina R.
Katabi, Nora
Pfister, David G.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.6093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6093
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase 2 Study of Apatinib, A Novel VEGFR Inhibitor in Patients With Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: Preliminary Results
    Dou, S.
    Zhang, L.
    Li, R.
    Zhu, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1378 - 1379
  • [42] Efficacy of cytotoxic chemotherapy in recurrent/metastatic adenoid cystic carcinoma (ACC)
    Wotman, Michael
    Hoff, Camilla Oliveira
    Bonini, Flavia
    Sawyer, Matthew
    Wang, Kaiwen
    Dal Lago, Eduardo Andreazza
    de Sousa, Luana Guimaraes
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma
    Lorini, Luigi
    Ardighieri, Laura
    Bozzola, Anna
    Romani, Chiara
    Bignotti, Eliana
    Buglione, Michela
    Guerini, Andrea
    Lombardi, Davide
    Deganello, Alberto
    Tomasoni, Michele
    Bonini, Sara Anna
    Sigala, Sandra
    Farina, Davide
    Ravanelli, Marco
    Bossi, Paolo
    ORAL ONCOLOGY, 2021, 115
  • [44] Phase II Study of RAD001 Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma
    Kim, D.
    Shin, S.
    Kang, J.
    Cho, B.
    Kim, H.
    Jung, J.
    Park, K.
    Kwon, J.
    Hang, J.
    Bang, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S544 - S544
  • [45] Phase II study on Lenvatinib in recurrent and/or metastatic adenoid cystic carcinomas (ACC) of the salivary glands of the upper aerodigestive tract
    Licitra, L.
    Pistillo, P.
    Locati, L. D.
    ANNALS OF ONCOLOGY, 2015, 26 : 70 - 70
  • [46] Antitumor activity of imatinib in progressive, highly expressing KIT adenoid cystic carcinoma of the salivary glands: A phase II study
    Guigay, J. M.
    Bidault, F.
    Temam, S.
    Janot, F.
    Raymond, E.
    Faivre, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC).
    Guigay, Joel
    Fayette, Jerome
    Even, Caroline
    Cupissol, Didier
    Rolland, Frederic
    Peyrade, Frederic
    Laguerre, Brigitte
    Le Tourneau, Christophe
    Zanetta, Sylvie
    Le Moal, Laurence Bozec
    Borel, Christian
    Do, Pascal
    Digue, Laurence
    Delaye, Jessy
    Auperin, Anne
    Bidault, Francois
    Costes, Valerie
    Faivre, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Metastatic Adenoid Cystic Carcinoma of the Eyelid
    Park, Do Young
    Lee, Jung Hye
    Suh, Yeon-Lim
    Woo, Kyung In
    Kim, Yoon-Duck
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 28 (05) : E111 - E113
  • [49] Metastatic Adenoid Cystic Carcinoma of the Breast
    Monga, Varun
    Leone, Jose Pablo
    BREAST JOURNAL, 2016, 22 (02) : 239 - 240
  • [50] A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma
    Hanna, Glenn J.
    Ahn, Myung-Ju
    Muzaffar, Jameel
    Keam, Bhumsuk
    Bowles, Daniel W.
    Wong, Deborah J.
    Ho, Alan L.
    Kim, Sung-Bae
    Worden, Francis
    Yun, Tak
    Meng, Xianzhang
    Van Tornout, Jan M.
    Conlan, Maureen G.
    Kang, Hyunseok
    CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4555 - 4563
12345